EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
Overall EQS gets a fundamental rating of 6 out of 10. We evaluated EQS against 10 industry peers in the Health Care Technology industry. EQS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EQS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
In the past year EQS had a positive cash flow from operations.
In the past 5 years EQS has always been profitable.
In the past 5 years EQS always reported a positive cash flow from operatings.
1.2 Ratios
EQS's Return On Assets of 9.10% is fine compared to the rest of the industry. EQS outperforms 80.00% of its industry peers.
EQS has a better Return On Equity (15.65%) than 90.00% of its industry peers.
EQS has a Return On Invested Capital of 12.02%. This is amongst the best in the industry. EQS outperforms 90.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 8.54%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROIC | 12.02% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS has a better Profit Margin (16.72%) than 90.00% of its industry peers.
EQS's Profit Margin has been stable in the last couple of years.
EQS has a better Operating Margin (20.18%) than 100.00% of its industry peers.
EQS's Operating Margin has declined in the last couple of years.
EQS's Gross Margin of 68.77% is on the low side compared to the rest of the industry. EQS is outperformed by 60.00% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQS is creating value.
EQS has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for EQS has been increased compared to 5 years ago.
The debt/assets ratio for EQS has been reduced compared to a year ago.
2.2 Solvency
EQS has an Altman-Z score of 4.55. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of EQS (4.55) is better than 90.00% of its industry peers.
The Debt to FCF ratio of EQS is 1.29, which is an excellent value as it means it would take EQS, only 1.29 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.29, EQS is doing good in the industry, outperforming 70.00% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that EQS is not too dependend on debt financing.
EQS has a better Debt to Equity ratio (0.12) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 4.55 |
ROIC/WACC1.58
WACC7.63%
2.3 Liquidity
A Current Ratio of 1.21 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Current ratio of 1.21. This is comparable to the rest of the industry: EQS outperforms 50.00% of its industry peers.
EQS has a Quick Ratio of 1.10. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.10, EQS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The earnings per share for EQS have decreased strongly by -23.02% in the last year.
The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
The Revenue has decreased by -1.37% in the past year.
EQS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.45% yearly.
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.54% on average per year.
Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.82, which indicates a rather expensive current valuation of EQS.
Compared to the rest of the industry, the Price/Earnings ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, EQS is valued a bit cheaper.
A Price/Forward Earnings ratio of 17.04 indicates a rather expensive valuation of EQS.
EQS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EQS is cheaper than 70.00% of the companies in the same industry.
EQS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.82 | ||
| Fwd PE | 17.04 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EQS is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 70.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.02 | ||
| EV/EBITDA | 12.48 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.54% in the coming years.
PEG (NY)0.76
PEG (5Y)4.06
EPS Next 2Y18.54%
EPS Next 3YN/A
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 2.49%.
EQS's Dividend Yield is comparable with the industry average which is at 4.20.
EQS's Dividend Yield is comparable with the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
EQS pays out 51.86% of its income as dividend. This is a bit on the high side, but may be sustainable.
EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.86%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPA:EQS (7/11/2025, 7:00:00 PM)
49.75
-0.45 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners10.49%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap754.71M
Analysts80
Price Target58.14 (16.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.86%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.2%
PT rev (3m)-18.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.82 | ||
| Fwd PE | 17.04 | ||
| P/S | 3.48 | ||
| P/FCF | 21.02 | ||
| P/OCF | 15.87 | ||
| P/B | 3.26 | ||
| P/tB | 9.25 | ||
| EV/EBITDA | 12.48 |
EPS(TTM)2.39
EY4.8%
EPS(NY)2.92
Fwd EY5.87%
FCF(TTM)2.37
FCFY4.76%
OCF(TTM)3.13
OCFY6.3%
SpS14.29
BVpS15.26
TBVpS5.38
PEG (NY)0.76
PEG (5Y)4.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROCE | 14.76% | ||
| ROIC | 12.02% | ||
| ROICexc | 14.31% | ||
| ROICexgc | 35.95% | ||
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% | ||
| FCFM | 16.57% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 79.39% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | 99.11% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.55 |
F-Score5
WACC7.63%
ROIC/WACC1.58
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
EBIT growth 1Y-20.84%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year71.53%
EBIT Next 3Y25.63%
EBIT Next 5YN/A
FCF growth 1Y-8.64%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-17.61%
OCF growth 3Y0.02%
OCF growth 5Y3.18%